サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1597071

アジア太平洋のバイオプロセス市場の将来予測 (2031年まで) - 地域別分析：製品別、事業規模別、プロセス別、用途別、エンドユーザー別

Asia Pacific Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product, Scale of Operation, Process, Application, and End User

出版日
ページ情報
英文 168 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
アジア太平洋のバイオプロセス市場の将来予測 (2031年まで) - 地域別分析：製品別、事業規模別、プロセス別、用途別、エンドユーザー別
出版日: 2024年10月03日
発行: The Insight Partners
ページ情報: 英文 168 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋のバイオプロセス市場は、2023年に54億8,887万米ドルと評価され、2031年には168億6,877万米ドルに達すると予測され、2023年から2031年までのCAGRは15.1%と推定されます。

個別化医療の需要拡大がアジア太平洋のバイオプロセス市場を後押し

医療産業が画一的なものから的を絞ったアプローチへと変化していることで、個別化医療の需要が拡大しています。精密医療は、がん、神経変性疾患、希少遺伝子疾患などの健康問題に取り組むための最も有望なアプローチの1つと考えられています。個別化医薬品の生産における革新は、この分野全体に影響を与える可能性が高く、少量生産を目的としたシングルユース技術は、特に下流工程におけるタンパク質バイオ生産に応用できる可能性があります。個別化・差別化された医療へのアプローチにより、より広範な製品が必要とされるようになっています。そのため、生物学的製剤の生産と送達には、これまでとは根本的に異なるアプローチが必要になるかもしれないです。精密医療は、個人のゲノム情報を活用し、特定の適応症に的を絞った治療を提供するものです。希少疾病の増加により生物製剤や医薬品への需要が高まり、それが個別化医療の成長を後押ししています。2019年、FDAは疾患の根本原因に対処するために12種前後の個別化医薬品を承認し、精密医療の臨床医療への統合を更に進めました。また、政府の取り組みが強化され、個別化医療の研究活動が強化されています。例えば、2020年2月、国立ヒトゲノム研究所 (NHGRI) は、新たな精密医療・ゲノミクスプログラムを設立すると発表しました。このプログラムは、より良い診断と治療のためのゲノミクスとインフォマティクス・ツールの革新に焦点を当てています。個別化医療は、遺伝学とバイオインフォマティクスの進歩を利用して、特定の患者集団をターゲットにし、これまで治療不可能であった病気を治療するものです。個別化医療は、オーダーメイドの治療法を開発するためにバイオ加工技術を利用します。特定の細胞の単離から患者固有の治療法の開発まで、バイオプロセス工程は各患者に合わせた治療法の製造に不可欠です。したがって、個別化医療に対する需要の高まりは、予測期間中、バイオプロセス市場で事業を展開する企業に大きな成長機会を提供すると予測されます。

アジア太平洋のバイオプロセス市場の概要

アジア太平洋のバイオプロセス市場は、中国、日本、インド、韓国、オーストラリア、その他アジア太平洋に区分されます。これらの国々における市場成長は、慢性疾患有病率の上昇と有利な償還政策に起因しています。さらに、市場参入企業が実施する拡大戦略や製品上市戦略は、同地域のバイオプロセス技術市場の成長に貢献すると期待されています。2023年には中国が市場の最大シェアを占め、予測期間中はインドが市場の大幅なCAGRを記録すると予想されます。中国のバイオ医薬品業界は、ジェネリック医薬品中心の状況からイノベーションの中心地へと大きく変化しています。さらに、工業化の進展と新薬、ハイエンド医療機器、技術の応用が、中国のバイオプロセス市場の成長に寄与しています。このように、研究センターの増加、政府からの資金提供の増加、市場参入企業による地理的拡大のための絶え間ない取り組みが、アジア太平洋におけるバイオプロセス市場の成長に拍車をかけています。

アジア太平洋のバイオプロセス市場の収益と2031年までの予測 (金額)

アジア太平洋のバイオプロセス市場のセグメンテーション

アジア太平洋のバイオプロセス市場は、製品、事業規模、プロセス、用途、エンドユーザー、国に分類されます。

製品別では、アジア太平洋のバイオプロセス市場は、装置と消耗品・アクセサリーに二分されます。2023年の市場シェアは、装置セグメントが大きいです。さらに、機器セグメントは、ろ過装置、バイオリアクター、クロマトグラフィーシステム、遠心分離機、乾燥装置、その他に細分化されます。さらに、バイオリアクターのサブセグメントは、パイロットスケール、フルスケール、ラボスケールに分類されます。さらに、クロマトグラフィーシステムのサブセグメントは、液体クロマトグラフィー、ガスクロマトグラフィー、その他に分類されます。さらに、消耗品・アクセサリーセグメントは、試薬、細胞培養メデューム、クロマトグラフィー樹脂、その他に細分化されています。

事業規模別では、アジア太平洋のバイオプロセス市場は商業運用と臨床運用に二分されます。2023年の市場シェアは、商業運用分野が大きいです。

プロセス別では、アジア太平洋のバイオプロセス市場は下流のバイオプロセスと上流のバイオプロセスに二分されます。2023年には下流バイオプロセス分野がより大きな市場シェアを占めています。

用途別では、アジア太平洋のバイオプロセス市場は、モノクローナル抗体、ワクチン、組み換えタンパク質、細胞・遺伝子治療、その他に分類されます。モノクローナル抗体セグメントは2023年に最大の市場シェアを占めました。

エンドユーザー別では、アジア太平洋のバイオプロセス市場はバイオ医薬品企業、CMO、その他に分類されます。バイオ医薬品会社セグメントが2023年に最大の市場シェアを占めました。

国別では、アジア太平洋バイオプロセス市場は、中国、インド、日本、韓国、オーストラリア、その他アジア太平洋に区分されます。2023年のアジア太平洋バイオプロセス市場シェアは中国が独占しています。

Getinge AB、Thermo Fisher Scientific Inc、Sartorius AG、Corning Inc、Bio-Rad Laboratories Inc、Merck KGaA、3M Co、Eppendorf SE、Repligen Corp、Entegris Inc、Agilent Technologies Inc、Cytiva US LLC. などが、アジア太平洋のバイオプロセス市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 アジア太平洋のバイオプロセス市場の情勢

  • エコシステム分析
    • バリューチェーンのベンダー一覧

第5章 アジア太平洋のバイオプロセス市場：主要市場力学

  • 市場促進要因
    • 慢性疾患の増加
    • バイオ医薬品産業の成長
  • 市場抑制要因
    • バイオプロセスに関連する厳しい規制政策と制限
  • 市場機会
    • 個別化医療への需要の高まり
  • 今後の動向
    • 細胞治療製造の自動化へのシフト
  • 促進要因と抑制要因の影響

第6章 アジア太平洋のバイオプロセス市場の分析

  • アジア太平洋のバイオプロセス市場の概要
  • バイオプロセス市場の売上高 (2021～2031年)

第7章 アジア太平洋のバイオプロセス市場の分析：製品別

  • 装置
  • 消耗品・アクセサリー

第8章 アジア太平洋のバイオプロセス市場の分析：事業規模別

  • 商業運用
  • 臨床運用

第9章 アジア太平洋のバイオプロセス市場の分析：プロセス別

  • 下流工程バイオプロセス
  • 上流工程バイオプロセス

第10章 アジア太平洋のバイオプロセス市場の分析：用途別

  • モノクローナル抗体
  • ワクチン
  • 組み換えタンパク質
  • 細胞・遺伝子治療
  • その他

第11章 アジア太平洋のバイオプロセス市場の分析：エンドユーザー別

  • バイオ医薬品企業
  • CMO (医薬品製造業務受託機関)
  • その他

第12章 アジア太平洋のバイオプロセス市場：国別分析

  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他のアジア太平洋諸国

第13章 業界情勢

  • バイオプロセス市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第14章 企業プロファイル

  • Getinge AB
  • Thermo Fisher Scientific Inc
  • Sartorius AG
  • Corning Inc
  • Bio-Rad Laboratories Inc
  • Merck KGaA
  • 3M Co
  • Eppendorf SE
  • Repligen Corp
  • Entegris Inc
  • Agilent Technologies Inc
  • Cytiva US LLC

第15章 付録

図表

List Of Tables

  • Table 1. Asia Pacific Bioprocessing Market Segmentation
  • Table 2. List of Vendors
  • Table 3. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
  • Table 4. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
  • Table 5. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
  • Table 6. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
  • Table 7. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 8. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
  • Table 9. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
  • Table 10. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
  • Table 11. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
  • Table 12. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
  • Table 13. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
  • Table 14. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 15. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 16. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 17. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
  • Table 18. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
  • Table 19. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
  • Table 20. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
  • Table 21. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
  • Table 22. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
  • Table 23. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 24. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 25. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 26. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
  • Table 27. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
  • Table 28. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
  • Table 29. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
  • Table 30. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
  • Table 31. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
  • Table 32. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 33. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 34. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 35. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
  • Table 36. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
  • Table 37. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
  • Table 38. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
  • Table 39. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
  • Table 40. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
  • Table 41. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 42. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 43. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 44. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
  • Table 45. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
  • Table 46. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
  • Table 47. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
  • Table 48. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
  • Table 49. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
  • Table 50. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 51. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 52. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 53. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
  • Table 54. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
  • Table 55. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
  • Table 56. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
  • Table 57. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
  • Table 58. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
  • Table 59. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 60. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 61. Recent Inorganic Growth Strategies in the Bioprocessing Market
  • Table 62. Recent Organic Growth Strategies in the Bioprocessing Market
  • Table 63. Glossary of Terms, Bioprocessing Market

List Of Figures

  • Figure 1. Asia Pacific Bioprocessing Market Segmentation, by Country
  • Figure 2. Bioprocessing Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031
  • Figure 5. Bioprocessing Market Share (%) - by Product (2023 and 2031)
  • Figure 6. Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Bioprocessing Market Share (%) - by Scale of Operation (2023 and 2031)
  • Figure 9. Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Bioprocessing Market Share (%) - by Process (2023 and 2031)
  • Figure 12. Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Bioprocessing Market Share (%) - by Application (2023 and 2031)
  • Figure 15. Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Bioprocessing Market Share (%) - by End User (2023 and 2031)
  • Figure 21. Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Asia Pacific: Bioprocessing Market, by Key Country - Revenue (2023) (US$ Million)
  • Figure 25. Asia Pacific: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 26. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 29. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 30. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 31. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 32. Growth Strategies in the Bioprocessing Market
目次
Product Code: BMIRE00030823

The Asia Pacific bioprocessing market was valued at US$ 5,488.87 million in 2023 and is expected to reach US$ 16,868.77 million by 2031; it is estimated to register a CAGR of 15.1% from 2023 to 2031.

Proliferating Demand for Personalized Medicine Boosts Asia Pacific Bioprocessing Market

The transformation of the healthcare industry from one-size-fits-all to a targeted approach is expanding the demand for personalized medicine. Precision medicine is being considered as one of the most promising approaches to tackle health concerns such as cancer, neurodegenerative diseases, and rare genetic conditions. Innovations in the production of personalized medicines are likely to impact the entire sector, and single-use technologies aimed at smaller-volume production have potential applications in protein bioproduction, particularly in downstream processes. Personalized and differentiated approaches to medicine are leading to a need for a wider range of products-many of them for a relatively small group of patients. Therefore, a fundamentally different approach to the production and delivery of biological products may be required. Precision medicine utilizes the genomic information of an individual to offer targeted treatment for a particular indication. The growing number of orphan diseases has increased the demand for biologics and drugs, which has subsequently boosted the growth of personalized medicines. In 2019, the FDA approved ~12 personalized medications for addressing the root causes of disease and further integrated precision medicine with clinical care. Also, increasing government efforts are strengthening personalized medicine research activities. For instance, in February 2020, the National Human Genome Research Institute (NHGRI) announced to establish a new precision medicine and genomics program. This program focuses on the innovation of genomics and informatics tools for better diagnosis and treatment of disease. Personalized medicines leverage advances in genetics and bioinformatics to target specific patient populations and treat previously untreatable diseases. Personalized medicine uses bioprocessing techniques to develop tailored therapies. From isolating specific cells to developing patient-specific treatments, bioprocessing steps are essential for producing treatments tailored to each patient. Therefore, the rising demand for personalized medicine is predicted to offer significant growth opportunities to the players operating in the bioprocessing market during the forecast period.

Asia Pacific Bioprocessing Market Overview

The Asia Pacific bioprocessing market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The market growth in these countries is attributed to the rising chronic disease prevalence and favorable reimbursement policies. Moreover, expansion and product launch strategies implemented by market players are expected to contribute to the growth of the bioprocess technology market in the region. China accounted for the largest share of the market in 2023, and India is expected to record a significant CAGR in the market during the forecast period. The biopharmaceutical industry in China is undergoing a tremendous shift, evolving from a generic-focused landscape to a thriving innovation hub. Additionally, progress in industrialization and the application of novel drugs, high-end medical devices, and techniques contribute to the bioprocessing market growth in China. Thus, an increasing number of research centers, rising government funding, and constant initiatives taken by the market players for geographic expansion fuel the bioprocessing market growth in Asia Pacific.

Asia Pacific Bioprocessing Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Bioprocessing Market Segmentation

The Asia Pacific bioprocessing market is categorized into product, scale of operation, process, application, end user, and country.

Based on product, the Asia Pacific bioprocessing market is bifurcated into instruments and consumables & accessories. The instruments segment held a larger market share in 2023. Furthermore, the instruments segment is sub segmented into filtration devices, bioreactors, chromatography systems, centrifuge, drying devices, and others. Additionally, the bioreactors subsegment is categorized into pilot scale, full scale, and laboratory scale. Furthermore, the subsegment chromatography systems is segmented into liquid chromatography, gas chromatography, and others. Additionally, the consumables & accessories segment is sub segmented into reagents, cell culture media, chromatography resins, and others.

In terms of scale of operation, the Asia Pacific bioprocessing market is bifurcated into commercial operations and clinical operations. The commercial operations segment held a larger market share in 2023.

By process, the Asia Pacific bioprocessing market is bifurcated into downstream bioprocess and upstream bioprocess. The downstream bioprocess segment held a larger market share in 2023.

Based on application, the Asia Pacific bioprocessing market is categorized into monoclonal antibodies, vaccines, recombinant protein, cell & gene therapy, and others. The monoclonal antibodies segment held the largest market share in 2023.

In terms of end user, the Asia Pacific bioprocessing market is categorized into biopharmaceutical companies, contract manufacturing organization, and others. The biopharmaceutical companies segment held the largest market share in 2023.

By country, the Asia Pacific bioprocessing market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific bioprocessing market share in 2023.

Getinge AB, Thermo Fisher Scientific Inc, Sartorius AG, Corning Inc, Bio-Rad Laboratories Inc, Merck KGaA, 3M Co, Eppendorf SE, Repligen Corp, Entegris Inc, Agilent Technologies Inc, and Cytiva US LLC. are some of the leading companies operating in the Asia Pacific bioprocessing market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Bioprocessing Market Landscape

  • 4.1 Ecosystem Analysis
    • 4.1.1 List of Vendors in the Value Chain

5. Asia Pacific Bioprocessing Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Prevalence of Chronic Diseases
    • 5.1.2 Growing Biopharmaceutical Industry
  • 5.2 Market Restraints
    • 5.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing
  • 5.3 Market Opportunities
    • 5.3.1 Proliferating Demand for Personalized Medicine
  • 5.4 Future Trends
    • 5.4.1 Shift Toward Automated Cell Therapy Manufacturing
  • 5.5 Impact of Drivers and Restraints:

6. Bioprocessing Market - Asia Pacific Analysis

  • 6.1 Asia Pacific Bioprocessing Market Overview
  • 6.2 Bioprocessing Market Revenue (US$ Million), 2021-2031

7. Asia Pacific Bioprocessing Market Analysis - by Product

  • 7.1 Overview
  • 7.2 Instruments
    • 7.2.1 Overview
    • 7.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
      • 7.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
        • 7.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
        • 7.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
  • 7.3 Consumables & Accessories
    • 7.3.1 Overview
    • 7.3.2 Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
      • 7.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories

8. Asia Pacific Bioprocessing Market Analysis - by Scale of Operation

  • 8.1 Overview
  • 8.2 Commercial Operations
    • 8.2.1 Overview
    • 8.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Clinical Operations
    • 8.3.1 Overview
    • 8.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9. Asia Pacific Bioprocessing Market Analysis - by Process

  • 9.1 Overview
  • 9.2 Downstream Bioprocess
    • 9.2.1 Overview
    • 9.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Upstream Bioprocess
    • 9.3.1 Overview
    • 9.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10. Asia Pacific Bioprocessing Market Analysis - by Application

  • 10.1 Overview
  • 10.2 Monoclonal Antibodies
    • 10.2.1 Overview
    • 10.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Vaccines
    • 10.3.1 Overview
    • 10.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Recombinant Protein
    • 10.4.1 Overview
    • 10.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Cell & Gene Therapy
    • 10.5.1 Overview
    • 10.5.2 Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11. Asia Pacific Bioprocessing Market Analysis - by End User

  • 11.1 Overview
  • 11.2 Biopharmaceutical Companies
    • 11.2.1 Overview
    • 11.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.3 Contract Manufacturing Organization
    • 11.3.1 Overview
    • 11.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.4 Others
    • 11.4.1 Overview
    • 11.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12. Asia Pacific Bioprocessing Market - Country Analysis

  • 12.1 Asia Pacific
    • 12.1.1 Asia Pacific: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
      • 12.1.1.1 China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.1.1 Overview
      • 12.1.1.2 China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.2.1 China: Bioprocessing Market Breakdown, by Product
        • 12.1.1.2.1.1 China: Bioprocessing Market Breakdown, by Instruments
        • 12.1.1.2.1.1.1 China: Bioprocessing Market Breakdown, by Bioreactors
        • 12.1.1.2.1.1.2 China: Bioprocessing Market Breakdown, by Chromatography Systems
        • 12.1.1.2.2 China: Bioprocessing Market Breakdown, by Consumables & Accessories
        • 12.1.1.2.3 China: Bioprocessing Market Breakdown, by Scale of Operation
        • 12.1.1.2.4 China: Bioprocessing Market Breakdown, by Process
        • 12.1.1.2.5 China: Bioprocessing Market Breakdown, by Application
        • 12.1.1.2.6 China: Bioprocessing Market Breakdown, by End User
      • 12.1.1.3 India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.3.1 Overview
      • 12.1.1.4 India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.4.1 India: Bioprocessing Market Breakdown, by Product
        • 12.1.1.4.1.1 India: Bioprocessing Market Breakdown, by Instruments
        • 12.1.1.4.1.1.1 India: Bioprocessing Market Breakdown, by Bioreactors
        • 12.1.1.4.1.1.2 India: Bioprocessing Market Breakdown, by Chromatography Systems
        • 12.1.1.4.1.2 India: Bioprocessing Market Breakdown, by Consumables & Accessories
        • 12.1.1.4.2 India: Bioprocessing Market Breakdown, by Scale of Operation
        • 12.1.1.4.3 India: Bioprocessing Market Breakdown, by Process
        • 12.1.1.4.4 India: Bioprocessing Market Breakdown, by Application
        • 12.1.1.4.5 India: Bioprocessing Market Breakdown, by End User
      • 12.1.1.5 Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.5.1 Overview
      • 12.1.1.6 Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.6.1 Japan: Bioprocessing Market Breakdown, by Product
        • 12.1.1.6.1.1 Japan: Bioprocessing Market Breakdown, by Instruments
        • 12.1.1.6.1.1.1 Japan: Bioprocessing Market Breakdown, by Bioreactors
        • 12.1.1.6.1.1.2 Japan: Bioprocessing Market Breakdown, by Chromatography Systems
        • 12.1.1.6.1.2 Japan: Bioprocessing Market Breakdown, by Consumables & Accessories
        • 12.1.1.6.2 Japan: Bioprocessing Market Breakdown, by Scale of Operation
        • 12.1.1.6.3 Japan: Bioprocessing Market Breakdown, by Process
        • 12.1.1.6.4 Japan: Bioprocessing Market Breakdown, by Application
        • 12.1.1.6.5 Japan: Bioprocessing Market Breakdown, by End User
      • 12.1.1.7 South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.7.1 Overview
      • 12.1.1.8 South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.8.1 South Korea: Bioprocessing Market Breakdown, by Product
        • 12.1.1.8.1.1 South Korea: Bioprocessing Market Breakdown, by Instruments
        • 12.1.1.8.1.1.1 South Korea: Bioprocessing Market Breakdown, by Bioreactors
        • 12.1.1.8.1.1.2 South Korea: Bioprocessing Market Breakdown, by Chromatography Systems
        • 12.1.1.8.1.2 South Korea: Bioprocessing Market Breakdown, by Consumables & Accessories
        • 12.1.1.8.2 South Korea: Bioprocessing Market Breakdown, by Scale of Operation
        • 12.1.1.8.3 South Korea: Bioprocessing Market Breakdown, by Process
        • 12.1.1.8.4 South Korea: Bioprocessing Market Breakdown, by Application
        • 12.1.1.8.5 South Korea: Bioprocessing Market Breakdown, by End User
      • 12.1.1.9 Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.9.1 Overview
      • 12.1.1.10 Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.10.1 Australia: Bioprocessing Market Breakdown, by Product
        • 12.1.1.10.1.1 Australia: Bioprocessing Market Breakdown, by Instruments
        • 12.1.1.10.1.1.1 Australia: Bioprocessing Market Breakdown, by Bioreactors
        • 12.1.1.10.1.1.2 Australia: Bioprocessing Market Breakdown, by Chromatography Systems
        • 12.1.1.10.1.2 Australia: Bioprocessing Market Breakdown, by Consumables & Accessories
        • 12.1.1.10.2 Australia: Bioprocessing Market Breakdown, by Scale of Operation
        • 12.1.1.10.3 Australia: Bioprocessing Market Breakdown, by Process
        • 12.1.1.10.4 Australia: Bioprocessing Market Breakdown, by Application
        • 12.1.1.10.5 Australia: Bioprocessing Market Breakdown, by End User
      • 12.1.1.11 Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.11.1 Overview
      • 12.1.1.12 Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.12.1 Rest of APAC: Bioprocessing Market Breakdown, by Product
        • 12.1.1.12.1.1 Rest of APAC: Bioprocessing Market Breakdown, by Instruments
        • 12.1.1.12.1.1.1 Rest of APAC: Bioprocessing Market Breakdown, by Bioreactors
        • 12.1.1.12.1.1.2 Rest of APAC: Bioprocessing Market Breakdown, by Chromatography Systems
        • 12.1.1.12.1.2 Rest of APAC: Bioprocessing Market Breakdown, by Consumables & Accessories
        • 12.1.1.12.2 Rest of APAC: Bioprocessing Market Breakdown, by Scale of Operation
        • 12.1.1.12.3 Rest of APAC: Bioprocessing Market Breakdown, by Process
        • 12.1.1.12.4 Rest of APAC: Bioprocessing Market Breakdown, by Application
        • 12.1.1.12.5 Rest of APAC: Bioprocessing Market Breakdown, by End User

13. Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in the Bioprocessing Market
  • 13.3 Inorganic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Organic Growth Strategies
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 Getinge AB
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Thermo Fisher Scientific Inc
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Sartorius AG
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Corning Inc
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Bio-Rad Laboratories Inc
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Merck KGaA
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 3M Co
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Eppendorf SE
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Repligen Corp
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Entegris Inc
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments
  • 14.11 Agilent Technologies Inc
    • 14.11.1 Key Facts
    • 14.11.2 Business Description
    • 14.11.3 Products and Services
    • 14.11.4 Financial Overview
    • 14.11.5 SWOT Analysis
    • 14.11.6 Key Developments
  • 14.12 Cytiva US LLC
    • 14.12.1 Key Facts
    • 14.12.2 Business Description
    • 14.12.3 Products and Services
    • 14.12.4 Financial Overview
    • 14.12.5 SWOT Analysis
    • 14.12.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms